Home > Term: hu14.18-interleukin-2 fusion protein
hu14.18-interleukin-2 fusion protein
An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.
- Part of Speech: noun
- Industry/Domain: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Creator
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
